Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-19Observational Study Published on 2022-05-012022-10-05 Journal: Clinical and experimental nephrology [Category] 임상, [키워드] 95%CI Acute kidney injury Admission AKI Atherosclerosis center chronic Chronic kidney disease CKD comparable consecutive patient Control control group control patient controls coronavirus COVID-19 COVID-19 infection COVID-19 outbreak COVID-19 outcomes creatinine Diabetes Mellitus died disease severity evaluated event Evidence Hospitalization Hospitalized hypertension infected with COVID-19 information kidney Kidney disease Older outcome Pathogenesis Patient patients Prevalence renal renal replacement therapy required retrospective serum serum creatinine severity significantly more Stage while [DOI] 10.1007/s10157-022-02180-6 PMC 바로가기 [Article Type] Observational Study
Organ dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort studyObservational Study Published on 2022-04-192022-10-04 Journal: CMAJ open [Category] COVID19(2023년), SARS, 임상, [키워드] 28-day mortality 95% CI 95% confidence interval acute COVID-19 adjusted Admission angiotensin receptor blocker ARB association average baseline characteristics changes in cohort study Community Comorbidity conducted COVID-19 pandemic death demographic characteristics Dexamethasone dysfunction examined excluded hospital Hospital admission IMPROVE in-hospital mortality Invasive mechanical ventilation less Logistic lower mortality management Mortality multicentre Observational cohort study Odds ratio organ support outcome outcomes pandemic Patient Pragmatic readmission Regression model remained renal dysfunction renal replacement therapy RRT severity of illness significantly lower therapy Vasopressor with COVID-19 [DOI] 10.9778/cmajo.20210216 PMC 바로가기 [Article Type] Observational Study
The use of standardized Brazilian green propolis extract (EPP-AF) as an adjunct treatment for hospitalized COVID-19 patients (BeeCovid2): a structured summary of a study protocol for a randomized controlled trial입원한 COVID-19 환자(BeeCovid2)의 보조 치료제로 표준화된 브라질 녹색 프로폴리스 추출물(EPP-AF)의 사용: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Article Published on 2022-04-042022-09-11 Journal: Trials [Category] 임상, [키워드] 1:1 2019 coronavirus disease ACE2 acute COVID-19 Acute kidney injury adjunct Administered adults hospitalized Affect affected age anti-inflammatory agents association Bacterial balloon pump Brazil Cancer patients chronic disease Chronic diseases Chronic kidney disease clinical study conducted coronavirus disease COVID-19 demonstrated diagnosis of COVID-19 double-blinded ECMO Effectiveness Evidence experimental evidence extracorporeal membrane oxygenation Fungal infection groups heart failure HIV patients Hospital stay hospitalized COVID-19 patient hospitalized patients immunoregulation Immunosuppression impacts impossibility include Infection intra-aortic balloon pump Kidney disease Liver disease mechanical ventilation medication moderate moderate to severe outcome PAK1 PAK1 blocker pandemic Patient patients hospitalized Placebo placebo-controlled clinical study pregnant women Primary outcome Propolis protocol randomization Randomized Randomized controlled trial receive reducing renal replacement therapy replacement therapy secondary Secondary infection Secondary outcomes severe liver disease Spread standard care Study protocol Symptom targets TMPRSS2 Treatment Trial vasoactive drugs with COVID-19 [DOI] 10.1186/s13063-022-06176-1 PMC 바로가기 [Article Type] Article
Echocardiographic predictors of mortality and morbidity in COVID-19 disease using focused cardiovascular ultrasoundResearch article Published on 2022-04-012022-10-05 Journal: IJC Heart & Vasculature [Category] 바이오마커, 진단, [키워드] adverse outcome analyzed association Cardiac imaging center Clinical outcome conducted COVID-19 COVID-19 disease COVID-19 pandemic Critical diagnostic died dysfunction echocardiographic parameter echocardiography female highlight hospitalized COVID-19 patients hospitalized patient implication Infection invasive ventilation knowledge LV dysfunction morbidity Mortality multivariable model Patient performed predictor Prognosis prognostic renal replacement therapy Result Retrospective study risk RV dysfunction Shock significantly university utility Venous Thromboembolism ventricular with COVID-19 [DOI] 10.1016/j.ijcha.2022.100982 [Article Type] Research article
Differences between COVID-19-induced acute kidney injury and chronic kidney disease patientsCOVID-19 유발 급성 신장 손상과 만성 신장 질환 환자의 차이점Article Published on 2022-04-012022-09-11 Journal: J Bras Nefrol [Category] COVID19(2023년), SARS, 치료기술, [키워드] Acute kidney injury AKI albumin Analysis Barranquilla cardiac disease Chronic kidney disease COVID-19 D-dimer level D-dimer levels diagnosis of COVID-19 difference English epidemiological data frailty Hospital stay hypertension incidence invasive ventilation Kidney disease majority material Mortality mortality rate Patient patients PCR performed positive positive PCR Prevalence reactive renal renal function renal replacement therapy replacement therapy SARS-CoV-2 serum serum parameters significantly higher statistical analysis treated was recorded were recorded [DOI] 10.1590/2175-8239-JBN-2021-0161 PMC 바로가기 [Article Type] Article
Early prediction of COVID-19-associated acute kidney injury: Are serum NGAL and serum Cystatin C levels better than serum creatinine?COVID-19 관련 급성 신장 손상의 조기 예측: 혈청 NGAL 및 혈청 시스타틴 C 수치가 혈청 크레아티닌보다 나은가요?Article Published on 2022-04-012022-09-11 Journal: Clinical biochemistry [Category] COVID19(2023년), SARS, 바이오마커, 진단, [키워드] acute kidney Acute kidney injury Admission AKI AUC Biomarker Biomarkers clinical settings comparable coronavirus coronavirus disease coronavirus disease-2019 COVID-19 COVID-19 patients creatinine cystatin C demonstrated Diagnosis diagnostic disease severity elevated emergency department etiologies high risk ICU ICU admission intensive care intensive care unit Intervention kidney Kidney injury Laboratory medicine laboratory-confirmed Laboratory-confirmed COVID-19 Mortality neutrophil predictor presenting Primary outcome renal replacement therapy replacement therapy risk stratification RRT SARS-CoV-2 secondary outcome Secondary outcomes sensitivity serum serum creatinine shown suggested utility while [DOI] 10.1016/j.clinbiochem.2022.01.006 PMC 바로가기 [Article Type] Article
Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort StudyResearch article Published on 2022-03-012022-10-05 Journal: The American journal of medicine [Category] 바이오마커, 유전자 메커니즘, 임상, 치료법, [키워드] adjusted analyses African Americans biomarkers of inflammation black Black patient Black race both group C-reactive protein clinical trial clinical trials collected data consecutive patient contribute convalescent serum coronavirus coronavirus disease Corticosteroid Corticosteroids COVID-19 death described determine Diabetes Mellitus difference Disparities enrolled Enrollment higher odd Hospitalization Hospitalized hypertension In-hospital inflammatory markers Inflammatory response less M2C2 mechanical ventilation Mortality not significant obesity outcome patients patients hospitalized patients with COVID-19 prevalence of COVID-19 Prospective prospective cohort study Racial receive receptor Remdesivir renal replacement therapy Result risk factor SARS-CoV-2 Therapies [DOI] 10.1016/j.amjmed.2021.10.026 [Article Type] Research article
Impact of COVID-19 Infection Among Heart Transplant Recipients: A Southern Brazilian ExperienceMedicine Published on 2022-02-092022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] Admission age Bacterial body mass index Brazil Chronic kidney disease Cohort comparable Complication complications cough COVID-19 COVID-19 infection COVID-19 vaccine death diabetes Dyspnea elevated experience Fever first dose first symptom Follow-up General population headache heart heart transplant high risk hospital Hospitalization hypertension Hypoxemia Immunosuppression Impact incidence of COVID-19 Infection intensive care Latin America majority male mechanical ventilation multiple organ dysfunction myalgia Patient patients patients died Pneumonia rates of infection recipient recipients reduction in renal replacement therapy reported required Result retrospective cohort Rio Grande Sepsis shown state supplementary oxygen Support Symptom therapy Transplant Venous Thromboembolism were infected [DOI] 10.3389/fmed.2022.814952 PMC 바로가기 [Article Type] Medicine
ICU-Associated Costs during the Fourth Wave of the COVID-19 Pandemic in a Tertiary Hospital in a Low-Vaccinated Eastern European CountryArticle Published on 2022-02-042022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] Antiviral calculated COVID-19 COVID-19 pandemic Critically ill patient demographic duration of hospitalization dysfunction European Healthcare system healthcare-associated costs hospital ICU identify immunomodulatory therapy increase in intensive care intensive care unit lung involvement management measure medication medication costs non-COVID-19 patient organ dysfunction pandemic Patient patients renal replacement therapy retrospective cohort risk factor Romania SARS-COV-2 infection severity Support Tertiary Treatment Wave were recorded [DOI] 10.3390/ijerph19031781 PMC 바로가기 [Article Type] Article
Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19Pharmacology Published on 2022-02-042022-10-31 Journal: Frontiers in Pharmacology [Category] COVID-19, [키워드] Admission alanine aminotransferase ALB albumin alleviate ALT Aspartate aminotransferase AST C-reactive protein circulating cytokine clinical collected Concentration Continuous Continuous renal replacement therapy control group coronavirus disease COVID-19 Critical CRP CRRT CRS Cytokine release syndrome Cytokine storm demographic determine fibrinogen Filter hospital Hospitalization hyper inflammation ICU IFN-γ IL-10 IL-2 IL-4 IL-6 individual inflammatory chemokines intervention group IRB lymphocyte Lymphocyte count medical records medical system neutrophil no significant difference non-acute kidney injury Organ failure oXiris filter Patient Platelet proportion Protein random number table randomly divided Release renal replacement therapy replacement Resolution SARS-COV-2 infection sensitivity serum creatinine severe and critical COVID-19 severity of COVID-19 significantly significantly higher significantly lower SOFA strained TNF-α total bilirubin treated Treatment two groups WBC White blood cell [DOI] 10.3389/fphar.2022.817793 PMC 바로가기 [Article Type] Pharmacology